This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Canman, C. E. Articles by Maybaum, J. Search for Related Content PubMed PubMed Citation Articles by Canman, C. E. Articles by Maybaum, J.

Induction of Resistance to Fluorodeoxyuridine Cytotoxicity and DNA Damage in Human Tumor Cells by Expression of Escherichia coli Deoxyuridinetriphosphatase¹

Departments of Pharmacology [C. E. C., L. A. P., J. M.] and Radiation Oncology [E. H. R., M. A. D., T. S. L.], University of Michigan Medical School, Ann Arbor, Michigan, 48109-0504

Recent studies from our laboratory suggested that, in some human colorectal tumor cell lines, sensitivity to fluorodeoxyuridine may depend upon the extent of dUTP accumulation that occurs following drug treatment and that elevation of dUTPase activity might be the basis for some instances of resistance to fluoropyrimidines. To test this model, we expressed Escherichia coli dUTPase in an established human tumor cell line (HT29) and measured the effect of this manipulation on response to fluorodeoxyuridine. As predicted, HT29 derivatives containing dUTPase activity 4–5-fold higher than controls were protected from fluorode-oxyuridine-induced loss of clonogenicity and from formation of DNA double strand breaks. These data provide the first direct evidence that alteration in a component of the uracil misincorporation/misrepair pathway can confer resistance to fluoropyrimidines in human tumor cells.

¹ This work was supported by NIH Grants CA42761 and CA56663 (J. M.), a Clinical Investigator award (K08-CA1590; E. H. R.), CA53440 (T. S. L.), GCRC Grant M01-RR00042, a Lawrence Upjohn fellowship (C. E. C.), and a Predoctoral Fellowship from the University of Michigan Medical School Cancer Research Committee (C. E. C.).

² Current address: Johns Hopkins Oncology Center, Oncology 2-109, 600 North Wolfe Street, Baltimore, MD 21287-5001.

³ To whom requests for reprints should be addressed, at 4701 Upjohn Center for Clinical Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109-0504.

Received 12/29/93. Accepted 3/18/94.

This article has been cited by other articles:

				P. M. Wilson, W. Fazzone, M. J. LaBonte, J. Deng, N. Neamati, and R. D. Ladner Novel opportunities for thymidylate metabolism as a therapeutic target Mol. Cancer Ther., September 1, 2008; 7(9): 3029 - 3037. [Abstract] [Full Text] [PDF]

				Q. An, P. Robins, T. Lindahl, and D. E. Barnes 5-Fluorouracil Incorporated into DNA Is Excised by the Smug1 DNA Glycosylase to Reduce Drug Cytotoxicity Cancer Res., February 1, 2007; 67(3): 940 - 945. [Abstract] [Full Text] [PDF]

				J. A. Fischer, S. Muller-Weeks, and S. J. Caradonna Fluorodeoxyuridine Modulates Cellular Expression of the DNA Base Excision Repair Enzyme Uracil-DNA Glycosylase. Cancer Res., September 1, 2006; 66(17): 8829 - 8837. [Abstract] [Full Text] [PDF]

				K. Dornfeld and M. Johnson AP endonuclease deficiency results in extreme sensitivity to thymidine deprivation Nucleic Acids Res., November 27, 2005; 33(20): 6644 - 6653. [Abstract] [Full Text] [PDF]

				S. Andersen, T. Heine, R. Sneve, I. Konig, H. E. Krokan, B. Epe, and H. Nilsen Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts Carcinogenesis, March 1, 2005; 26(3): 547 - 555. [Abstract] [Full Text] [PDF]

				W. Choi, E. W. Gerner, L. Ramdas, J. Dupart, J. Carew, L. Proctor, P. Huang, W. Zhang, and S. R. Hamilton Combination of 5-Fluorouracil and N1,N11-Diethylnorspermine Markedly Activates Spermidine/Spermine N1-Acetyltransferase Expression, Depletes Polyamines, and Synergistically Induces Apoptosis in Colon Carcinoma Cells J. Biol. Chem., February 4, 2005; 280(5): 3295 - 3304. [Abstract] [Full Text] [PDF]

				O. Barabas, V. Pongracz, J. Kovari, M. Wilmanns, and B. G. Vertessy Structural Insights into the Catalytic Mechanism of Phosphate Ester Hydrolysis by dUTPase J. Biol. Chem., October 8, 2004; 279(41): 42907 - 42915. [Abstract] [Full Text] [PDF]

				L. A. Parsels, J. D. Parsels, D. C.-H. Tai, D. J. Coughlin, and J. Maybaum 5-Fluoro-2'-Deoxyuridine-Induced cdc25A Accumulation Correlates with Premature Mitotic Entry and Clonogenic Death in Human Colon Cancer Cells Cancer Res., September 15, 2004; 64(18): 6588 - 6594. [Abstract] [Full Text] [PDF]

				S. E. Koehler and R. D. Ladner Small Interfering RNA-Mediated Suppression of dUTPase Sensitizes Cancer Cell Lines to Thymidylate Synthase Inhibition Mol. Pharmacol., September 1, 2004; 66(3): 620 - 626. [Abstract] [Full Text] [PDF]

				L. Li, S. H. Berger, and M. D. Wyatt Involvement of base excision repair in response to therapy targeted at thymidylate synthase Mol. Cancer Ther., June 1, 2004; 3(6): 747 - 753. [Abstract] [Full Text] [PDF]

				A. Bekesi, I. Zagyva, E. Hunyadi-Gulyas, V. Pongracz, J. Kovari, A. O. Nagy, A. Erdei, K. F. Medzihradszky, and B. G. Vertessy Developmental Regulation of dUTPase in Drosophila melanogaster J. Biol. Chem., May 21, 2004; 279(21): 22362 - 22370. [Abstract] [Full Text] [PDF]

				J. Kovari, O. Barabas, E. Takacs, A. Bekesi, Z. Dubrovay, V. Pongracz, I. Zagyva, T. Imre, P. Szabo, and B. G. Vertessy Altered Active Site Flexibility and a Structural Metal-binding Site in Eukaryotic dUTPase: KINETIC CHARACTERIZATION, FOLDING, AND CRYSTALLOGRAPHIC STUDIES OF THE HOMOTRIMERIC DROSOPHILA ENZYME J. Biol. Chem., April 23, 2004; 279(17): 17932 - 17944. [Abstract] [Full Text] [PDF]

				B. A. Tinkelenberg, M. J. Hansbury, and R. D. Ladner dUTPase and Uracil-DNA Glycosylase Are Central Modulators of Antifolate Toxicity in Saccharomyces cerevisiae Cancer Res., September 1, 2002; 62(17): 4909 - 4915. [Abstract] [Full Text] [PDF]

				H. Nilsen and H. E. Krokan Base excision repair in a network of defence and tolerance Carcinogenesis, July 1, 2001; 22(7): 987 - 998. [Full Text] [PDF]

				R. D. Ladner, F. J. Lynch, S. Groshen, Y. P. Xiong, A. Sherrod, S. J. Caradonna, J. Stoehlmacher, and H.-J. Lenz dUTP Nucleotidohydrolase Isoform Expression in Normal and Neoplastic Tissues: Association with Survival and Response to 5-Fluorouracil in Colorectal Cancer Cancer Res., July 1, 2000; 60(13): 3493 - 3503. [Abstract] [Full Text]

				S. Wadler, S. Damle, H. Haynes, R. Kaleya, R. Schechner, R. Berkenblit, R. D. Ladner, and A. Murgo Phase II/Pharmacodynamic Trial of Dose-Intensive, Weekly Parenteral Hydroxyurea and Fluorouracil Administered With Interferon Alfa-2a in Patients With Refractory Malignancies of the Gastrointestinal Tract J. Clin. Oncol., June 1, 1999; 17(6): 1771 - 1771. [Abstract] [Full Text] [PDF]

				L. A. Parsels, R. C. Zellars, T. L. Loney, J. D. Parsels, M. F. Clarke, A. K. Merchant, T. S. Lawrence, and J. Maybaum Prevention of Fluorodeoxyuridine-Induced Cytotoxicity and DNA Damage in HT29 Colon Carcinoma Cells by Conditional Expression of Wild-Type p53 Phenotype Mol. Pharmacol., October 1, 1997; 52(4): 600 - 605. [Abstract] [Full Text]

				R. D. Ladner and S. J. Caradonna The Human dUTPase Gene Encodes both Nuclear and Mitochondrial Isoforms. DIFFERENTIAL EXPRESSION OF THE ISOFORMS AND CHARACTERIZATION OF A cDNA ENCODING THE MITOCHONDRIAL SPECIES J. Biol. Chem., July 25, 1997; 272(30): 19072 - 19080. [Abstract] [Full Text] [PDF]

				R. D. Ladner, D. E. McNulty, S. A. Carr, G. D. Roberts, and S. J. Caradonna Characterization of Distinct Nuclear and Mitochondrial Forms of Human Deoxyuridine Triphosphate Nucleotidohydrolase J. Biol. Chem., March 29, 1996; 271(13): 7745 - 7751. [Abstract] [Full Text] [PDF]